The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations?

MeSH terms

• Adrenergic beta-Antagonists / adverse effects
• Adrenergic beta-Antagonists / pharmacology
• Adrenergic beta-Antagonists / therapeutic use
• Angiotensin-Converting Enzyme Inhibitors / adverse effects
• Angiotensin-Converting Enzyme Inhibitors / pharmacology
• Angiotensin-Converting Enzyme Inhibitors / therapeutic use
• Antihypertensive Agents / adverse effects
• Antihypertensive Agents / pharmacology
• Antihypertensive Agents / therapeutic use*
• Blood Glucose / drug effects
• Blood Pressure / drug effects
• Calcium Channel Blockers / adverse effects
• Calcium Channel Blockers / pharmacology
• Calcium Channel Blockers / therapeutic use
• Diabetes Mellitus, Type 2 / epidemiology
• Diuretics / adverse effects
• Diuretics / pharmacology
• Diuretics / therapeutic use
• Humans
• Hypertension / complications
• Hypertension / drug therapy*
• Lipids / blood
• Metabolic Syndrome / complications
• Metabolic Syndrome / drug therapy*
• Risk Factors